BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18469848)

  • 1. The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats.
    Schäfer A; Pfrang J; Neumüller J; Fiedler S; Ertl G; Bauersachs J
    Br J Pharmacol; 2008 Jul; 154(5):1047-54. PubMed ID: 18469848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rimonabant in rats with a metabolic syndrome: good news after the depression.
    Di Marzo V; Szallasi A
    Br J Pharmacol; 2008 Jul; 154(5):915-7. PubMed ID: 18454166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
    Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
    Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
    Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity.
    Wang Q; Perrard XD; Perrard JL; Mansoori A; Smith CW; Ballantyne CM; Wu H
    Obesity (Silver Spring); 2011 Mar; 19(3):505-13. PubMed ID: 20885384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats.
    Janiak P; Poirier B; Bidouard JP; Cadrouvele C; Pierre F; Gouraud L; Barbosa I; Dedio J; Maffrand JP; Le Fur G; O'Connor S; Herbert JM
    Kidney Int; 2007 Dec; 72(11):1345-57. PubMed ID: 17882151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with the cannabinoid 1 antagonist rimonabant altered vasoactive cyclo-oxygenase-derived products on arteries from obese Zucker rats.
    Mingorance C; de Sotomayor MA; Marhuenda E; Herrera MD
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):560-9. PubMed ID: 20729749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets.
    Getty-Kaushik L; Richard AM; Deeney JT; Krawczyk S; Shirihai O; Corkey BE
    Obesity (Silver Spring); 2009 Oct; 17(10):1856-60. PubMed ID: 19644453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats.
    Croci T; Zarini E
    Br J Pharmacol; 2007 Mar; 150(5):559-66. PubMed ID: 17245360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats.
    Doyon C; Denis RG; Baraboi ED; Samson P; Lalonde J; Deshaies Y; Richard D
    Diabetes; 2006 Dec; 55(12):3403-10. PubMed ID: 17130486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose.
    Schäfer A; Widder J; Eigenthaler M; Bischoff H; Ertl G; Bauersachs J
    Thromb Haemost; 2004 Jul; 92(1):97-103. PubMed ID: 15213850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats.
    Rasmussen EB; Huskinson SL
    Behav Pharmacol; 2008 Oct; 19(7):735-42. PubMed ID: 18797250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.
    Vickers SP; Webster LJ; Wyatt A; Dourish CT; Kennett GA
    Psychopharmacology (Berl); 2003 Apr; 167(1):103-11. PubMed ID: 12632249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on food intake and blood lipids of cannabinoid receptor 1 antagonist treatment in lean rats.
    Bennetzen MF; Nielsen MP; Richelsen B; Pedersen SB
    Obesity (Silver Spring); 2008 Nov; 16(11):2451-5. PubMed ID: 18719671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic treatment with the CB1 antagonist, rimonabant on the blood pressure, and vascular reactivity of obese Zucker rats.
    Mingorance C; Alvarez de Sotomayor M; Jiménez-Palacios FJ; Callejón Mochón M; Casto C; Marhuenda E; Herrera MD
    Obesity (Silver Spring); 2009 Jul; 17(7):1340-7. PubMed ID: 19553924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome.
    Slavic S; Lauer D; Sommerfeld M; Kemnitz UR; Grzesiak A; Trappiel M; Thöne-Reineke C; Baulmann J; Paulis L; Kappert K; Kintscher U; Unger T; Kaschina E
    J Mol Med (Berl); 2013 Jul; 91(7):811-23. PubMed ID: 23636507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rimonabant, the cannabinoid CB1 receptor antagonist, on peripheral nerve in streptozotocin-induced diabetic rat.
    Liu WJ; Jin HY; Park JH; Baek HS; Park TS
    Eur J Pharmacol; 2010 Jul; 637(1-3):70-6. PubMed ID: 20406631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential response of platelets to chemokines: RANTES non-competitively inhibits stimulatory effect of SDF-1 alpha.
    Shenkman B; Brill A; Brill G; Lider O; Savion N; Varon D
    J Thromb Haemost; 2004 Jan; 2(1):154-60. PubMed ID: 14717979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism.
    Cota D; Sandoval DA; Olivieri M; Prodi E; D'Alessio DA; Woods SC; Seeley RJ; Obici S
    Obesity (Silver Spring); 2009 Aug; 17(8):1641-5. PubMed ID: 19325539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.